ArticleThe American journal of case reports2025
Primary Cardiac Myxofibrosarcoma of the Left Atrium with Heterologous Elements Mimicking a Cardiac Myxoma.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Distinguishing Cardiac Sarcomas From Lymphomas: Comparative Insights From Clinical and Echocardiographic Characteristics.Echocardiography (Mount Kisco, N.Y.) · 2026Observational
- Left atrial primary intimal sarcoma mimicking myxoma: case report.European heart journal. Case reports · 2026Article
- Case report of an aggressive cardiac myxofibrosarcoma with rapid disease progression.European heart journal. Case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Primary cardiac malignancies are extremely rare, with an incidence of 0.07% on autopsy series. Primary sarcomas represent up to 95% of malignant neoplasms, with myxofibrosarcomas accounting for only 10%. Around 90% of patients present with unspecific symptoms and a tumor with polypoid appearance on imaging, thus frequently receiving a misdiagnosis of myxoma. CASE REPORT A 65-year-old man presented with abrupt chest pain, blood pressure of 130/80 mmHg, and heart rate of 180 beats/min. Electrocardiogram showed atrial fibrillation, and imaging revealed a polypoid tumor on the atrioventricular septum obstructing the mitral valve. The tumor was removed and sent for histopathological evaluation, revealing a multinodular pattern with spindled hypocellular areas and hypercellular areas featuring pleomorphic cells. The mitotic count was 11 in 10 high-power fields, and necrosis was present in less than 50% of the tumor area. Tumor cells were calretinin and MDM2 negative and CD34 positive. Heterologous elements, necrosis and hemorrhage, were noted. Considering these findings, this tumor was classified as intermediate-grade myxofibrosarcoma. CONCLUSIONS Due to the rarity of myxofibrosarcomas, evidence for optimal diagnostic and therapeutic management is limited. Despite being frequently polypoid, seemingly benign tumors on imaging, the extent of infiltration at their base is usually deep. Their innocent appearance can hinder adequate presurgical planning, leading to suboptimal resections. We present the example of a seemingly benign tumor as a potential pitfall in evaluating cardiac neoplasms, highlighting the importance of histopathological and immunohistochemical evaluation in their correct characterization, in order to offer the best follow-up and adjuvant treatment, when needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.